There are 2789 resources available
1275P - Mutational landscape of non-small cell lung carcinoma in patients with different types of premalignant bronchial lesions
Presenter: Tatiana Gerashchenko
Session: ePoster Display
1276P - Deep molecular characterization of never smoker non-small cell lung cancer (NSCLC) patients
Presenter: Chiara Dellepiane
Session: ePoster Display
1277P - Molecular features in young non-small cell lung cancer: A comparative analysis
Presenter: Tongmei Zhang
Session: ePoster Display
1278P - SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-β, as first-line therapy for PD-L1+ advanced/metastatic NSCLC: Data from a clinical expansion cohort of a phase I study
Presenter: Jifeng Feng
Session: ePoster Display
1279P - The prognostic value of chemotherapy-induced neutropenia (CIN) in patients with advanced non-small cell lung cancer (NSCLC) in the era of chemoimmunotherapy (CIT)
Presenter: Alexander Meisel
Session: ePoster Display
1280P - Sitravatinib + tislelizumab in patients with metastatic non-small cell lung cancer (NSCLC)
Presenter: Qing Zhou
Session: ePoster Display
1282P - Biology of immune resistance in oncogenic driven advanced non-small cell lung cancer (aNSCLC)
Presenter: Mihaela Aldea
Session: ePoster Display
1283P - Predicting the differential diagnosis of pneumonitis in stage IV non-small cell lung cancer (NSCLC) patients treated with immune checkpoint inhibitors (ICIs) by combining clinical and radiomic features
Presenter: Fariba Tohidinezhad
Session: ePoster Display
1209P - RELAY, ramucirumab plus erlotinib (RAM+ERL) in untreated metastatic EGFR-mutant NSCLC (EGFR+NSCLC): Association between TP53 status and clinical outcome
Presenter: Makoto Nishio
Session: ePoster Display